Improving Postoperative Analgesia After Functional Endoscopic Surgery
1 other identifier
interventional
20
1 country
1
Brief Summary
Improving postoperative analgesia after functional endoscopic surgery: Sphenopalatine ganglion block versus soaked nasal packing using bupivacaine and dexmedetomidine
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2
Started Apr 2026
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 14, 2026
CompletedStudy Start
First participant enrolled
April 15, 2026
CompletedFirst Posted
Study publicly available on registry
April 29, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 30, 2026
April 29, 2026
April 1, 2026
7 months
April 14, 2026
April 21, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
effectiveness of SPGB with bupivacaine and dexmedetomidine for postoperative analgesia
Numeric rating scale for pain will be assessed and recorded within the first 24 hours where 1 means the worst pain and 10 means no pain. Total rescue analgesia in 24 H when Numeric rating scale ≥ 4 was recorded and the first time when it was given will be recorded.
6 months
Study Arms (2)
group a
EXPERIMENTALSphenopalatine ganglion block (SPGB) with Bupivacaine and Dexmedetomidine
druop b
EXPERIMENTALSphenopalatine ganglion block (SPGB) with Bupivacaine and Dexmedetomidine
Interventions
Sphenopalatine ganglion block (SPGB) with Bupivacaine and Dexmedetomidine
Eligibility Criteria
You may qualify if:
- Age 18 - 60 years
- ASA physical status I -II
- Patients scheduled for elective FESS
You may not qualify if:
- Allergy to drugs used
- Coagulopathy or anticoagulant therapy
- Severe cardiovascular, renal and hepatic disease
- Chronic opioid use Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut university hospital
Asyut, 161715, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- anesthesia consultant
Study Record Dates
First Submitted
April 14, 2026
First Posted
April 29, 2026
Study Start
April 15, 2026
Primary Completion (Estimated)
October 30, 2026
Study Completion (Estimated)
October 30, 2026
Last Updated
April 29, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share